Jie Shao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Emergency Department

Ulcerative Colitis

Top Venues

Clinical pharmacology and therapeutics

Journal of clinical pharmacology

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Jie Jessie Zhou, Yan Xu, Yang Chen, Jie Shao, Yaming Su, Zhenhua Xu, Honghui Zhou, Christopher O'Brien
Model-based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti- Natural Killer Group 2 Member D (NKG2D) Monoclonal Antibody, in Moderately to Severely Active Crohn's Disease. Journal of clinical pharmacology (2023)
Jie Shao, Mong-Jen Chen, Philip J Kuehl, Guenther Hochhaus
Pharmacokinetic and pharmacodynamic modeling of gut hormone peptide YY(3-36) after pulmonary delivery. Drug development and industrial pharmacy 45 (7) (2019)